Prot# CLO34100405: A Phase III Randomized, Double-Blind, Controlled Study Comparing Clofarabine and Cytarabine versus Cytarabine Alone in Adult Patients 55 Years and Older with Acute Myelogenous Leukemia (AML) Who Have Relapsed or are Refractory after Rec

Project: Research project

Project Details

StatusFinished
Effective start/end date7/21/087/21/11

Funding

  • Genzyme Corporation (CLO34100405)